Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Mauricio Ocqueteau"'
Autor:
Mauricio Sarmiento, Veronica Jara, Katherine Soto, Pablo Uribe, Mauricio Ocqueteau, Pablo Bertin, Jaime Pereira
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 3, Pp 303-308 (2021)
Introduction: Graft-versus-host disease (GVHD) is a serious complication in allogeneic transplantation. The first-line treatment is high doses of corticosteroids. In the absence of response to corticosteroids, several immunosuppressive drugs can be u
Externí odkaz:
https://doaj.org/article/2cded7ee6d6446beb0b41ac1e4b72cdf
Autor:
Mauricio Sarmiento, Pablo Ramirez, Veronica Jara, Pablo Bertin, Mauricio Galleguillos, Isabel Rodriguez, Carla Lorca, Isabel Pizarro, Elizabeth Rivera, Mauricio Ocqueteau
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 1, Pp 40-45 (2020)
Introduction: Patients with benign or malignant blood disorders, who require allogeneic stem cell transplantation and lack an identical human leukocyte antigen HLA identicalHL sibling donor, could be transplanted with hematopoietic stem cells from un
Externí odkaz:
https://doaj.org/article/103f0c268ee549909b64b6b1494c014b
Autor:
Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón
Publikováno v:
Experimental Hematology & Oncology, Vol 6, Iss 1, Pp 1-9 (2017)
Abstract Background Ruxolitinib is a potent inhibitor of JAK1/2 with proven efficacy in myelofibrosis. In recent years, research in graft versus host disease (GVHD) has revealed the role of activation of JAK pathways in alloreactive lymphocytes. Some
Externí odkaz:
https://doaj.org/article/7840b2d58f9743b79988cbc36a8f2f07
Autor:
Javier Pilcante, Patricio Rojas, Daniel Ernst, Mauricio Sarmiento, Mauricio Ocqueteau, Pablo Bertin, Maria García, Maria Rodriguez, Veronica Jara, Maria Ajenjo, Pablo Ramirez
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 37, Iss 6, Pp 388-394 (2015)
ABSTRACT Introduction: Patients submitted to hematopoietic stem cell transplantation have an increased risk of Clostridium difficile infection and multiple risk factors have been identi- fied. Published reports have indicated an incidence from 9% t
Externí odkaz:
https://doaj.org/article/167e72b6f13c40149cdd37ef9b1186b0
Autor:
Pablo Ramirez, Mauricio Ocqueteau, Alejandra Rodriguez, Maria Jose Garcia, Mauricio Sarmiento, Daniel Ernst, Veronica Jara, Pablo Bertin
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 37, Iss 3, Pp 184-189 (2015)
Introduction: Hodgkin's lymphoma is a highly curable disease. Autologous and reduced intensity allogeneic hematopoietic cell transplantations are alternatives to treat relapsed patients. Here, we report on the results of one service using these proce
Externí odkaz:
https://doaj.org/article/6ab0aa62ed2f4b53bd8bda9595f05aac
Autor:
Mauricio Sarmiento Maldonado, Mauricio Ocqueteau Tachini, Javier Pilcante, Pablo Ramírez Villanueva
Publikováno v:
Medwave, Vol 15, Iss 07, Pp e6207-e6207 (2015)
INTRODUCCIÓN La leucemia mieloide aguda tiene una alta mortalidad sin tratamiento. El trasplante hematopoyético es la única estrategia curativa hasta ahora. Los pacientes que tienen contraindicaciones para el trasplante, pueden ser tratados con f
Externí odkaz:
https://doaj.org/article/b39ff14ebdd446348fd0ea0d51ce413d
Autor:
Marcela Espinoza Zelada, Nicole Befferman Cordova, Mauricio Ocqueteau Tachin, Pablo Ramírez Villanueva, Mauricio Galleguillos M., Mauricio Sarmiento Maldonado
Publikováno v:
Medwave, Vol 15, Iss 02, p e6098 (2015)
INTRODUCTION Bortezomib is a selective inhibitor of the proteosoma that is used in multiple myeloma. In combination with other antineoplastic drugs, it has a well-documented impact in progression-free survival rates and overall survival rates with s
Externí odkaz:
https://doaj.org/article/a4d614086e9840a29865d4cce0b65845
Autor:
Patricia Macanas-Pirard, Andrea Leisewitz, Richard Broekhuizen, Kelly Cautivo, Francisco M Barriga, Francisco Leisewitz, Victoria Gidi, Erick Riquelme, Viviana P Montecinos, Pilar Swett, Pelayo Besa, Pablo Ramirez, Mauricio Ocqueteau, Alexis M Kalergis, Matthew Holt, Michael Rettig, John F DiPersio, Bruno Nervi
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37203 (2012)
BACKGROUND: Despite a high response rate to chemotherapy, the majority of patients with acute myeloid leukemia (AML) are destined to relapse due to residual disease in the bone marrow (BM). The tumor microenvironment is increasingly being recognized
Externí odkaz:
https://doaj.org/article/ac58465ead124ae08d7178bf23733a40
Autor:
Mauricio Sarmiento, Patricio Rojas, Catherine Gutierrez, Jacqueline Quezada, Veronica Jara, James Campbell, Garcia Maria, null Jose, null VicenteSandoval, Max Vergara, Nicolas Triantafilo, Mauricio Ocqueteau
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b294a78ea155e8257a67449f04f36b7
https://doi.org/10.1016/j.clml.2023.04.001
https://doi.org/10.1016/j.clml.2023.04.001
Autor:
Nicolás Triantafilo, Mauricio Sarmiento, James Campbell, Patricio Rojas, María José García, Vicente Sandoval, Pablo Bertín, Mauricio Ocqueteau, María Concepciãn Risueño, Isabel Rodríguez, Mauricio Galleguillos
Publikováno v:
Revista médica de Chile. 150:643-649
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::144944080b3a1d328aa6697cd36c2899
https://doi.org/10.4067/s0034-98872022000500643
https://doi.org/10.4067/s0034-98872022000500643